HONG KONG, July 28 (Reuters) – Shanghai Fosun Pharmaceutical
Group Co Ltd has agreed to buy Gland
Pharma – which is backed by KKR & Co LP – for about $1.4
billion, a person with direct knowledge of…
The post Fosun agrees to buy KKR-backed Indian drug maker for $1.4 bln -source appeared first on NASDAQ.